Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Roman Byshovets
Observed name:
Роман Бишовець
Institution:
Bogomolets National Medical University
Observed institution:
Bogomolets National Medical University
ORCID:
0009-0001-2257-9792
Observed ORCID:
0009-0001-2257-9792
OpenAlex ID:
A5031346690
Anti-inflammatory effects of 64Zn-aspartate is accompanied by cognitive improvements in rats with Aβ1-40-induced alzheimer disease
2025
·
Max Temnik
, Mariia Rudyk
, et al.
·
Scientific Reports
·
6
PDF
Zn64 aspartate modulates inflammation, tryptophan metabolism, and pancreatic function in diet-induced obesity
2025
·
Max Temnik
, Sergey Gurin
, et al.
·
Scientific Reports
·
4
PDF
Therapeutic potential of zinc 64Zn aspartate for obesity management: impact on oxidative stress, lipid metabolism, pancreas and liver in high-calorie diet model
2025
·
Max Temnik
, Sergey Gurin
, et al.
·
Frontiers in Pharmacology
·
4
PDF
Intravenous 64zn-Aspartate Mitigates Neuroinflammation and Motor Dysfunction in an Lps-Induced Parkinson’s Disease Rat Model
2025
·
Max Temnik
, Mariia Rudyk
, et al.
·
Journal of Neuroimmune Pharmacology
·
2
PDF
Isotopically enriched 64ZN-aspartate attenuates systemic inflammation and gut dysbiosis in an LPS-induced rat model of Parkinson’s disease
2026
·
Max Temnik
, Mariia Rudyk
, et al.
·
Scientific Reports
·
1
PDF
Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative Diseases
2022
·
Jesus A Perez
, Javier J Lopez
, et al.
·
Cureus
·
1
PDF
Лікування Подагри У Пацієнтів З Хронічною Хворобою Нирок: Клінічні Аспекти Та Сучасні Стратегії
2025
·
Віталій Кондратюк
, Роман Бишовець
·
Actual Problems of Nephrology
Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative Diseases
2022
·
Jesus A Perez
, Javier J Lopez
, et al.
·
Cureus
Show more works
View as search
Works count:
8
Citation count:
18
H-index:
3
I10-index:
Year
Topic
Type